RxDoctor Payments Data

Kristen Wright

Nurse Practitioner · Camden, NJNPI 1841755014

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.2% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AstraZeneca at 37.3% of the total. Among nurse practitioner clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,736in general payments, 2019–2025

Across 78 payments — averaging $47.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • E.r. Squibb & Sons, L.L.C.$558
  • Daiichi Sankyo Inc.$423
  • Amgen$380
  • Novartis$218
  • AbbVie$125
  • plus $640 from 14 others

What the payments were for

  • Food & beverage$3,40791%
  • Education$3299%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,736 in reported general payments places this provider in the 90th percentile of 2,138 nurse practitioner providers in New Jersey.

See all nurse practitioner providers in New Jersey →

Medicare billing

Part B allowed, 2024
$12,115
Medicare patients
106
Services billed
250

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XalkoriCrizotinib13$296,889
Imatinib Mesylate12$53,244
EliquisApixaban24$16,736
XareltoRivaroxaban12$7,838
Dexamethasone67$373
Ondansetron OdtOndansetron38$209
Prochlorperazine Maleate24$197
Mirtazapine16$193
Lidocaine-PrilocaineLidocaine/Prilocaine13$144
Gabapentin17$126
Oxycodone Hcl13$86

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Camden

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →